美国公共通道除器的潜在成本效益
G Nichol1, A P Hallstrom, J P Ornato
1Loeb Medical Research Institute, University of Ottawa, Canada.
Circulation
|May 7, 1998
概括
公共通道除动器 (PAD) 可能为突然心脏骤停提供良好的价值,尽管成本高于标准紧急医疗服务 (EMS). 需要进一步的试验来确认PAD干预措施的成本效益.
科学领域:
- 卫生经济学 卫生经济学
- 紧急医疗 紧急医疗
- 公共卫生干预 公共卫生干预
背景情况:
- 突然心脏骤停每年影响36万美国人,目前的治疗方法昂贵且无效.
- 公共通道除动器 (PAD) 是由非专业人士或警察使用的自动外部除动器,用于医院外的突然心脏骤停.
- PAD的经济价值仍然不清楚,需要进行成本效益分析.
研究的目的:
- 与标准紧急医疗服务 (EMS) 相比,估计公共通道除 (PAD) 的潜在成本效益.
- 评估涉及美国医疗保健系统中外界应急人员或警察的PAD干预措施.
主要方法:
- 一个决策模型将标准EMS与通过PAD补充的EMS进行了比较.
- 使用蒙特卡洛模拟和灵敏度分析来评估成本效益和可变性.
- 数据来源于已发表的文献和财政数据库,未来成本和影响的折扣率为3%.
主要成果:
- 标准的EMS平均每名患者的费用为5900美元,产生0.25个质量调整寿命年 (QALY).
- 没有响应者的PAD平均每QALY增加成本为44,000美元.
- 警方的PAD平均每QALY增加成本为27,200美元,结果对成本和生存效益敏感.
结论:
- PAD比标准的EMS更昂贵,但对于突然心脏骤停来说,它可能在经济上具有吸引力.
- 该研究建议在随机对照试验中评估PAD的有效性和成本效益.
更多相关视频
08:00Reduction of Iatrogenic Atrial Septal Defects with an Anterior and Inferior Transseptal Puncture Site when Operating the Cryoballoon Ablation Catheter
Published on: June 15, 2015
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
相关概念视频
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiopulmonary Resuscitation III: AED Use
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
